Palo Alto’s StemCells won federal approval for the first time Thursday to transplant fetal stem cells into human brains, to correct a fatal disorder in children. StemCells is working researchers at Stanford University. The stem cells to be transplanted aren’t from human embryos, which are subject to federal research restrictions. Instead, the cells are later-stage fetal neural cells that are destined to turn into the mature cells that make up a fully formed brain.
VentureBeatVentureBeat's mission is to be a digital town square for technical decision-makers to gain knowledge about transformative technology and transact. Our site delivers essential information on data technologies and strategies to guide you as you lead your organizations. We invite you to become a member of our community, to access:
- up-to-date information on the subjects of interest to you
- our newsletters
- gated thought-leader content and discounted access to our prized events, such as Transform 2021: Learn More
- networking features, and more